Acquisition by Bollard Catherine of 22000 shares of Cabaletta Bio at 10.01 subject to Rule 16b-3

CABA Stock  USD 1.57  0.13  7.65%   
About 68% of Cabaletta Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Cabaletta Bio suggests that many traders are alarmed. The current market sentiment, together with Cabaletta Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Cabaletta Bio stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Cabaletta Bio Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 22000 stock option (right to buy) at 10.01 of Cabaletta Bio by Bollard Catherine on 24th of January 2025. This event was filed by Cabaletta Bio with SEC on 2024-06-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Cabaletta Bio's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cabaletta Bio's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Cabaletta Bio Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Cabaletta Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cabaletta Bio Historical Investor Sentiment

Investor biases related to Cabaletta Bio's public news can be used to forecast risks associated with an investment in Cabaletta. The trend in average sentiment can be used to explain how an investor holding Cabaletta can time the market purely based on public headlines and social activities around Cabaletta Bio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cabaletta Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cabaletta Bio and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Cabaletta Bio news discussions. The higher the estimate score, the more favorable the investor's outlook on Cabaletta Bio.

Cabaletta Bio Fundamental Analysis

We analyze Cabaletta Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cabaletta Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cabaletta Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Cabaletta Bio is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Cabaletta Bio Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cabaletta Bio stock to make a market-neutral strategy. Peer analysis of Cabaletta Bio could also be used in its relative valuation, which is a method of valuing Cabaletta Bio by comparing valuation metrics with similar companies.

Peers

Cabaletta Bio Related Equities

ACLXArcellx   0.90   
0%
15.0%
MDGLMadrigal Pharmaceuticals   0.41   
0%
7.0%
DAWNDay One   0.15   
2.0%
0%
ETNB89bio   0.90   
15.0%
0%
ALECAlector   1.33   
23.0%
0%
RVMDRevolution Medicines   1.52   
26.0%
0%
LRMRLarimar Therapeutics   1.62   
28.0%
0%
STOKStoke Therapeutics   1.77   
30.0%
0%
PLRXPliant Therapeutics   3.85   
67.0%
0%
BDTXBlack Diamond   4.47   
78.0%
0%
PASGPassage Bio   5.71   
100.0%
0%

Complementary Tools for Cabaletta Stock analysis

When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets